Benjamin Garmezy, MD
Investigator, Sarah Cannon Research Institute at Tennessee Oncology
Benjamin Garmezy, MD, joined Sarah Cannon in 2021 as an Investigator for Sarah Cannon Research Institute at Tennessee Oncology, specializing in genitourinary (GU) oncology research. In his role, Dr. Garmezy oversees investigational therapy trials for GU cancers, including prostate, kidney, and bladder cancers.
Dr. Garmezy received his undergraduate degree from Amherst College and his Doctorate of Medicine from Baylor College of Medicine. Prior to joining Sarah Cannon, he completed his internal medicine residency at the University of Michigan and his fellowship in hematology/oncology at The University of Texas MD Anderson Cancer Center.